VIR logo

Vir Biotechnology (VIR) Cash From Financing

Annual CFF

$4.39 M
-$3.09 M-41.34%

December 31, 2024


Summary


Performance

VIR Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVIRcash flowmetrics:

Quarterly CFF

$1.26 M
+$1.23 M+3974.19%

December 31, 2024


Summary


Performance

VIR Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVIRcash flowmetrics:

TTM CFF

$4.39 M
-$417.00 K-8.68%

December 31, 2024


Summary


Performance

VIR TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVIRcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

VIR Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-41.3%-57.1%-13.1%
3 y3 years-95.6%-46.1%-53.4%
5 y5 years-99.0%-46.1%-53.4%

VIR Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-95.6%at low-95.4%+3974.2%-95.6%at low
5 y5-year-99.2%at low-99.6%+587.6%-99.3%at low
alltimeall time-99.2%at low-99.6%+587.6%-99.3%at low

Vir Biotechnology Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$4.39 M(-41.3%)
$1.26 M(+3974.2%)
$4.39 M(-8.7%)
Sep 2024
-
$31.00 K(-98.9%)
$4.80 M(-4.9%)
Jun 2024
-
$2.94 M(+1835.5%)
$5.05 M(-4.5%)
Mar 2024
-
$152.00 K(-91.0%)
$5.29 M(-29.3%)
Dec 2023
$7.48 M(-78.5%)
$1.68 M(+506.5%)
$7.48 M(-4.2%)
Sep 2023
-
$277.00 K(-91.3%)
$7.81 M(-17.9%)
Jun 2023
-
$3.18 M(+35.6%)
$9.52 M(+1.1%)
Mar 2023
-
$2.34 M(+16.6%)
$9.42 M(-72.9%)
Dec 2022
$34.76 M(-65.4%)
$2.01 M(+1.3%)
$34.76 M(-9.5%)
Sep 2022
-
$1.99 M(-35.6%)
$38.42 M(-4.1%)
Jun 2022
-
$3.08 M(-88.9%)
$40.06 M(-1.1%)
Mar 2022
-
$27.68 M(+388.3%)
$40.51 M(-59.6%)
Dec 2021
$100.33 M
$5.67 M(+56.2%)
$100.33 M(+6.3%)
DateAnnualQuarterlyTTM
Sep 2021
-
$3.63 M(+2.8%)
$94.40 M(-77.3%)
Jun 2021
-
$3.53 M(-96.0%)
$415.08 M(-32.7%)
Mar 2021
-
$87.50 M(<-9900.0%)
$616.89 M(+16.5%)
Dec 2020
$529.47 M(+17.9%)
-$259.00 K(-100.1%)
$529.47 M(-19.8%)
Sep 2020
-
$324.31 M(+57.9%)
$659.83 M(+95.6%)
Jun 2020
-
$205.34 M(>+9900.0%)
$337.26 M(+155.7%)
Mar 2020
-
$85.00 K(-99.9%)
$131.92 M(-70.6%)
Dec 2019
$449.24 M(+1698.6%)
$130.10 M(+7411.5%)
$449.24 M(+40.8%)
Sep 2019
-
$1.73 M(>+9900.0%)
$319.14 M(+0.5%)
Jun 2019
-
$3000.00(-100.0%)
$317.41 M(+0.0%)
Mar 2019
-
$317.41 M
$317.41 M
Dec 2018
$24.98 M(-90.8%)
-
-
Dec 2017
$271.18 M
-
-

FAQ

  • What is Vir Biotechnology annual cash flow from financing activities?
  • What is the all time high annual CFF for Vir Biotechnology?
  • What is Vir Biotechnology annual CFF year-on-year change?
  • What is Vir Biotechnology quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Vir Biotechnology?
  • What is Vir Biotechnology quarterly CFF year-on-year change?
  • What is Vir Biotechnology TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Vir Biotechnology?
  • What is Vir Biotechnology TTM CFF year-on-year change?

What is Vir Biotechnology annual cash flow from financing activities?

The current annual CFF of VIR is $4.39 M

What is the all time high annual CFF for Vir Biotechnology?

Vir Biotechnology all-time high annual cash flow from financing activities is $529.47 M

What is Vir Biotechnology annual CFF year-on-year change?

Over the past year, VIR annual cash flow from financing activities has changed by -$3.09 M (-41.34%)

What is Vir Biotechnology quarterly cash flow from financing activities?

The current quarterly CFF of VIR is $1.26 M

What is the all time high quarterly CFF for Vir Biotechnology?

Vir Biotechnology all-time high quarterly cash flow from financing activities is $324.31 M

What is Vir Biotechnology quarterly CFF year-on-year change?

Over the past year, VIR quarterly cash flow from financing activities has changed by -$1.68 M (-57.07%)

What is Vir Biotechnology TTM cash flow from financing activities?

The current TTM CFF of VIR is $4.39 M

What is the all time high TTM CFF for Vir Biotechnology?

Vir Biotechnology all-time high TTM cash flow from financing activities is $659.83 M

What is Vir Biotechnology TTM CFF year-on-year change?

Over the past year, VIR TTM cash flow from financing activities has changed by -$663.00 K (-13.13%)